Introduction Gene therapy is a promising strategy for the treatment of genetic disorders. In this context, a safe and efficient transfer of genetic material into target cells (i.e. transfection), i.e. the successful introduction of exogenous nucleic acids (DNA or RNA) through the cell membrane, is required [1-2]. Over the past two decades, considerable progress has been made in gene transfer technologies, and thus far, different delivery strategies have been developed. Chemical gene delivery vectors utilize specialized non-viral carriers, such as cationic polymers, to overcome the cellular barriers and ease the transfer of exogenously delivered nucleic acids into cells [3-4]. In this light, gene transfer mediated by cationic polymer/DNA co...
Introduction: In the past decades, the rise of nanotechnology and gene therapy have brought new hop...
[[abstract]]Purpose: Polyethylenimine (PEI), a cationic polymer, has been shown to aggregate plasmid...
INTRODUCTION: The main challenge of gene delivery is the design of effective and non-cytotoxic non-v...
Introduction Gene therapy is a promising strategy for the treatment of genetic disorders. In this c...
INTRODUCTION: The major drawback in the use of non-viral means for gene delivery purposes stands in ...
Purpose/Objectives: One major drawback of non-viral gene delivery means stands in the lack of suitab...
The main challenge of non-viral gene delivery is the design of effective and non-cytotoxic vectors a...
Introduction Since their first introduction, non-viral vectors for gene delivery purposes have made...
Introduction: Non-viral gene delivery strategies emerged as a new breakthrough for clinical and rese...
Introduction Despite the recent success of COVID-19 vaccines, the use of non-viral carriers, namely...
Background: With the success of recent non-viral gene delivery-based COVID-19 vaccines, nanovectors ...
Introduction: Non-viral gene delivery employs positively charged lipidic or polymeric vectors to dri...
Introduction: Non-viral vectors are cationic lipids or polymers that spontaneously assemble with nuc...
Introduction: In the past decades, the rise of nanotechnology and gene therapy have brought new hop...
[[abstract]]Purpose: Polyethylenimine (PEI), a cationic polymer, has been shown to aggregate plasmid...
INTRODUCTION: The main challenge of gene delivery is the design of effective and non-cytotoxic non-v...
Introduction Gene therapy is a promising strategy for the treatment of genetic disorders. In this c...
INTRODUCTION: The major drawback in the use of non-viral means for gene delivery purposes stands in ...
Purpose/Objectives: One major drawback of non-viral gene delivery means stands in the lack of suitab...
The main challenge of non-viral gene delivery is the design of effective and non-cytotoxic vectors a...
Introduction Since their first introduction, non-viral vectors for gene delivery purposes have made...
Introduction: Non-viral gene delivery strategies emerged as a new breakthrough for clinical and rese...
Introduction Despite the recent success of COVID-19 vaccines, the use of non-viral carriers, namely...
Background: With the success of recent non-viral gene delivery-based COVID-19 vaccines, nanovectors ...
Introduction: Non-viral gene delivery employs positively charged lipidic or polymeric vectors to dri...
Introduction: Non-viral vectors are cationic lipids or polymers that spontaneously assemble with nuc...
Introduction: In the past decades, the rise of nanotechnology and gene therapy have brought new hop...
[[abstract]]Purpose: Polyethylenimine (PEI), a cationic polymer, has been shown to aggregate plasmid...
INTRODUCTION: The main challenge of gene delivery is the design of effective and non-cytotoxic non-v...